Literature DB >> 7737173

Site-directed mutagenesis of the redox-active cysteines of Trypanosoma cruzi trypanothione reductase.

A Borges1, M L Cunningham, J Tovar, A H Fairlamb.   

Abstract

The gene for trypanothione reductase from the Silvio strain of Trypanosoma cruzi has been cloned, sequenced and overexpressed in Escherichia coli using the constitutive lpp promoter on the expression plasmid pBSTNAV. Up to 13% of the total soluble protein is enzymically active trypanothione reductase with kinetic properties similar to the enzyme purified from T. cruzi. In order to assess the catalytic role of the putative active-site cysteine residues (C53 and C58), three mutant proteins have been constructed by site-directed mutagenesis substituting alanine or serine residues for cysteine; [C53A]trypanothione reductase, [C53S]trypanothione reductase and [C58S]trypanothione reductase. Although the purified, recombinant mutant proteins were catalytically inactive with NADPH and trypanothione disulphide as substrates, all showed comparable levels of transhydrogenase activity between NADPH and thio-NADP+, suggesting that the mutant proteins had correctly folded in vivo. All three mutants showed substantially different catalytic parameters for thio-NADP+ than the wild-type enzyme, presumably as a consequence of modifying the environment of the enzyme-bound flavin, thereby altering its chemical reactivity. The purified [C58S]trypanothione reductase showed spectral properties similar to the oxidised wild-type enzyme but, unlike the wild-type enzyme, did not acquire the characteristic charge-transfer complex of the EH2 form on addition of NADPH. In contrast, in the absence of NADPH both [C53A]trypanothione reductase and [C53S]trypanothione reductase showed spectral properties similar to the EH2 form of the wild-type enzyme. These data indicate that both C53 and C58 are essential for overall catalysis, with the thiolate anion of C58 interacting with the enzyme-bound FAD and C53 interacting with the disulphide substrate. These mutants should be useful in crystallographic studies of reaction intermediates which cannot be obtained with the catalytically active native enzyme.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737173     DOI: 10.1111/j.1432-1033.1995.tb20319.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Transgenic biosynthesis of trypanothione protects Escherichia coli from radiation-induced toxicity.

Authors:  Matthew P Fitzgerald; Joshua M Madsen; Mitchell C Coleman; Melissa L T Teoh; Scott G Westphal; Douglas R Spitz; Rafael Radi; Frederick E Domann
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

2.  Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity.

Authors:  Georgina A Holloway; William N Charman; Alan H Fairlamb; Reto Brun; Marcel Kaiser; Edmund Kostewicz; Patrizia M Novello; John P Parisot; John Richardson; Ian P Street; Keith G Watson; Jonathan B Baell
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

3.  Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase.

Authors:  Chris J Hamilton; Ahilan Saravanamuthu; Ian M Eggleston; Alan H Fairlamb
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

4.  Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival.

Authors:  J Tovar; M L Cunningham; A C Smith; S L Croft; A H Fairlamb
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity.

Authors:  Derek C Martyn; Deuan C Jones; Alan H Fairlamb; Jon Clardy
Journal:  Bioorg Med Chem Lett       Date:  2006-12-09       Impact factor: 2.823

6.  Bis-acridines as lead antiparasitic agents: structure-activity analysis of a discrete compound library in vitro.

Authors:  Conor R Caffrey; Dietmar Steverding; Ryan K Swenerton; Ben Kelly; Deirdre Walshe; Anjan Debnath; Yuan-Min Zhou; Patricia S Doyle; Aaron T Fafarman; Julie A Zorn; Kirkwood M Land; Jessica Beauchene; Kimberly Schreiber; Heidrun Moll; Alicia Ponte-Sucre; Tanja Schirmeister; Ahilan Saravanamuthu; Alan H Fairlamb; Fred E Cohen; James H McKerrow; Jennifer L Weisman; Barnaby C H May
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

7.  Murine macrophages use oxygen- and nitric oxide-dependent mechanisms to synthesize S-nitroso-albumin and to kill extracellular trypanosomes.

Authors:  A P Gobert; S Semballa; S Daulouede; S Lesthelle; M Taxile; B Veyret; P Vincendeau
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design.

Authors:  Ahilan Saravanamuthu; Tim J Vickers; Charles S Bond; Mark R Peterson; William N Hunter; Alan H Fairlamb
Journal:  J Biol Chem       Date:  2004-04-21       Impact factor: 5.157

9.  A comparative study of type I and type II tryparedoxin peroxidases in Leishmania major.

Authors:  Janine König; Alan H Fairlamb
Journal:  FEBS J       Date:  2007-10-08       Impact factor: 5.542

10.  Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi.

Authors:  Deuan C Jones; Antonio Ariza; Wing-Huen A Chow; Sandra L Oza; Alan H Fairlamb
Journal:  Mol Biochem Parasitol       Date:  2009-09-10       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.